Could a common allergy drug boost brain power in kids with williams syndrome?
NCT ID NCT06315699
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called clomastine fumarate in 28 children aged 3-12 with Williams syndrome, a genetic condition that causes developmental delays. The goal was to see if the drug could improve thinking, movement, and social skills by repairing brain myelin. The study used brain scans and developmental tests to measure effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
Tainan, Shangdong, 250012, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could starting feeds sooner shield preterm babies from infection?
- Drawing, stories, or toy masks: a trial tests whether fun can tame kids' fear of nebulizer treatment
- Can early parent coaching help infants with rare genetic disorders thrive?
- Virtual reality reveals how Kids' hearing develops in chaotic soundscapes
- Can a 12-week virtual program get latina girls moving more?
- Family program aims to shield kids of melanoma survivors from the sun